the CDKN2A gene, encoding a tumor suppressor gene p16, was found to be mutated in some patients with FAMMM in addition to other cancer types [40]
This may make them useful for gut-focused goals, but it can also limit how much reaches the rest of the body
at the same 1:2000 as before), the c-met binding index was still higher than the control HGF ( bar 8 ) and the original LASSS/peroxynitrite-pretreated HGF (1:4000
When combined with tirzepatide which already causes nausea in 3045% of patients during dose titration distinguishing which compound is responsible becomes difficult
It's important to remember its not a magic bullet, of course
In summary, you can generally continue your other medications while on NAD+ injections, but keep your medical team informed and always follow their advice if they prefer to adjust dosing schedules or monitor certain lab parameters